A United Kingdom supplier, with 7 awarded contracts, totalling £90.5m, most recently 8 months ago.
This contract involves the procurement of medical equipment and supplies necessary for patients enrolled in the National Diabetes Program in Romania. Interested suppliers can request clarifications or additional information regarding the tender documentation until 16 days before the submission deadl
This procurement opportunity is for the acquisition of consumables for Type 1 diabetes patients under our care, specifically for the Dexcom One Plus continuous glucose monitoring system. The initiative is in line with the national diabetes program and aims to provide necessary supplies to patients w
This contract involves the supply of a continuous blood glucose monitoring system and compatible insulin delivery devices for the OMNIPOD DASH insulin pump. The procurement is divided into two lots, with detailed descriptions and quantities provided in the specifications document. The framework agre
This contract involves the supply of medical consumables for continuous blood glucose monitoring systems, specifically for Lot 1 (Type 1 Sensors) and Lot 2 (Type 2 Sensors). The minimum and maximum quantities are detailed in the specifications document. Subsequent contracts will be established based
This framework agreement is for the supply of medical consumables as specified in the data sheet and technical specifications. According to Article 161 of Law 98/2016, suppliers can request clarifications until 20 days before the deadline for submitting offers. The contracting authority will respond
This framework agreement is for the supply of medical consumables as specified in the data sheet and technical specifications. According to Article 161 of Law 98/2016, suppliers can request clarifications until 20 days before the deadline for submitting offers. The contracting authority will respond
This contract involves the procurement of sanitary materials for a patient monitoring system, specifically consumables for continuous blood glucose monitoring and insulin pumps. The framework agreement will be established with a maximum of three economic agents and will last for 24 months. The estim